Charles Schiffer is an Oncology physician affiliated with The Barbara Ann Karmanos Cancer Institute. OpenAlex indexes 399 publications with 37,603 citations (h-index 78); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Medical Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4100 John R St
Detroit, MI 482012013
Telephone
800-527-6266Registry record last updated 22 Sept 2016.
Clinical trials
- Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia
Sponsor: Barbara Ann Karmanos Cancer Institute
- S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome
Sponsor: SWOG Cancer Research Network
- Trial to Reduce Alloimmunization to Platelets (TRAP)
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
15 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- UROGEN PHARMA, INC.Program year20258 payments$14,579openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year20253 payments
- E.R. Squibb & Sons, L.L.C.Program year202416 payments$12,909openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Journal of Clinical Oncology
2017 - Dasatinib in imatinib‐resistant or ‐intolerant chronic‐phase, chronic myeloid leukemia patients: 7‐year follow‐up of study CA180‐034
American Journal of Hematology
2016 - In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs
Mayo Clinic Proceedings
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Joseph Uberti, MD, PhD
The Barbara Ann Karmanos Cancer Institute
Jose Larios, MD
The Barbara Ann Karmanos Cancer Institute
Borys Hrinczenko, MD
The Barbara Ann Karmanos Cancer Institute
Andrew Kin, MD
The Barbara Ann Karmanos Cancer Institute
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”